|
|
| S |
M |
T |
W |
T |
F |
S |
| |
|
|
|
1
|
2
|
3
|
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
Today is Sep 5, 2010
|
|
|
| January 28, 2004 |
| Time: |
12:00 PM to 1:30 PM |
| Topic: |
Implementation of the New EU Clinical Directive (Effective May 2004) with Specific Focus on Performing Clinical Research Work in the Netherlands |
| Speaker: |
Dick Veldhuis, PhD, Clinical Pharmacologist, Pharm |
| Speaker's Website: |
http://www.pbr.nl |
|
Download Presentation 1 |
| Location: |
Alza Corporation |
|
1900 Charleston Road |
|
Main Lobby, Building M10 |
|
Mountain View, California |
|
Get Map and Directions |
|
|
The EU Clinical Trials Directive will be fully implemented in May 2004. The purpose of the directive is to improve the quality of clinical research, protect trial subjects and ensure credible and accurate results. It will apply to all clinical trials involving medicinal products with exception of non-interventional trials. Trials sponsored by industry, government, research council or charity are included as are trials with placebo or existing drug used for a new indication.
Directions:
From 101 North take the Shoreline Blvd exit, left at the traffic lights, left on to Charleston Road, go straight for two blocks and we're the red buildings on the right side of Charleston Road. Follow the visitor parking signs,
From 101 South take the Shoreline Blvd exit, turn left and over the overpass, turn left on to Charleston Road, go straight for two blocks and we're the red buildings on the right side of Charleston Road. Follow the visitor parking signs.
NOTE: Please arrive 10 minutes early to register at the lobby. Lunch is available for purchase at the Alza cafeteria located in the same building.
|
|
| Speaker Biography |
|
Dick Veldhuis gained an MSc in Biochemistry in 1978, followed by a PhD in Psychoneuropharmacology in 1982 at the Rudolf Magnus Institute for Pharmacology at the University of Utrecht. After a post-doc period at the Institute, during which he wrote more than 40 full papers/chapters, he moved to the Pharmaceutical Industry.
He has held various research and managerial positions during a 16-year period at Eli Lilly and Company in the Netherlands, the UK and the USA, ranging from overseeing Clinical Research in Europe, managing Clinical Project Management and Data Management for Eli Lilly worldwide, as well as supporting European regulatory activities. He is currently employed as Director Clinical Pharmacology at Pharma Bio-Research Group BV in the Netherlands.
|